[Treatment of primary lipoproteinemia type IIa and IIb with highly purified dextro-thyroxine (D-T4). Controlled study in ambulant conditions].
D000284:Administration, Oral; D000553:Ambulatory Care; D000787:Angina Pectoris / Q000188:drug therapy; D000818:Animals; D001835:Body Weight; D002784:Cholesterol / Q000097:blood; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy* / Q000473:pathology; D008077:Lipoproteins, LDL / Q000097:blood*; D008297:Male; D008722:Methods; D010919:Placebos; D013223:Statistics as Topic; D013974:Thyroxine / Q000008:administration & dosage / Q000302:isolation & purification / Q000627:therapeutic use*; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D008077:Lipoproteins, LDL; D010919:Placebos; D014280:Triglycerides; D002784:Cholesterol; D013974:Thyroxine
Behandlung primärer Hyperlipoproteinämien vom Typ IIa und IIb mit hochgereinigtem D-Thyroxin (D-T4). Eine kontrollierte Studie unter ambulanten Bedingungen